Inventor
Jean-Georges Teutsch
Inventor
Pantin, FR
Overview
Patents· 69 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07JSteroids30%
C07DHeterocyclic compounds17%
C07CAcyclic or carbocyclic compounds7%
A61KPreparations for medical, dental or toiletry purposes4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
C07HSugars1%
Y02ATechnologies for adaptation to climate change1%
Y02PClimate change mitigation technologies in the production or processing of goods1%
PatentTitleYear
6,794,415'Biphenyl compounds and their use as oestrogenic agents'20046,790,971'19-Nor-steroids'20046,596,885'19-Nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, their use as medicaments and compositions'20036,563,008'Biphenyl compounds and their use as oestrogenic agents'20036,541,464'Steroids substituted at the 11-position, process for their preparation, their use as medicament and the pharmaceutical compositions containing them'20036,492,536'Steroids, their use as medicaments, their preparation process, the intermediates of this process and the compositions containing them'20026,482,813'Steroids substituted at the 11-position, process for their preparation, their use as medicament and the pharmaceutical compositions containing them'20026,472,382'4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them'20026,462,211'4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them'20026,459,001'Tricyclic compounds, their preparation process and the intermediates of this process, their use as medicaments and the pharmaceutical compositions containing them'20026,399,766'4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them'20026,288,126'Biphenyl compounds and use thereof as oestrogenic agents'20016,281,204'19-nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, and the intermediates of this process, their use as medicaments and compositions'20016,274,572'Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds'20016,242,611'Phenylimidazolidines containing nitrooxy or carbonyloxy groups'20016,239,121'4- Halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing same'20016,221,907'Tricyclic compounds having activity specific for integrins, particularly alphanubeta3 integrins, method for preparing same, intermediates therefor, use of said compounds as drugs, and pharmaceutical compositions containing same'20016,207,657'Steroids substituted in position 11, method of preparation, application as medicines and pharmaceutical compositions containing them'20016,011,026'Method of treating menopause or perimenopause'20005,981,516'Method of treating menopause or perimenopause'19995,965,763'Biphenyl compounds'19995,958,936'Imidazolidines substituted with a heterocycle'1999RE035956'Phenylimidazolidines having antiandrogenic activity'19985,827,887'Biphenyl compounds'19985,750,553'Optionally substituted phenylimidazolidines, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them'19985,707,982'19-nor-steroids'19985,705,654'Imidazolidines substituted with a heterocycle'19985,705,494'Anti-estrogenic activity of II.beta.-substituted-19-NOR Steroids'19985,683,996'4-thia-1-aza-bicyclo›4,2,0!oct-2-ene antibiotics'19975,679,788'11 beta-substituted-19 nor-steroids'19975,663,164'1-dethia-2-thia-cephalosporanic acids'19975,646,172'Method of inducing antiandrogenic activity using imidazolidines substituted with a heterocycle'19975,627,201'Phenylimidazolidines having antiandrogenic activity'19975,621,095'Cephalosporins'19975,589,497'Phenylimidazolidines'19965,556,845'11-.beta. substituted-19-nor steroids'19965,556,983'Phenylimidazolidines'19965,538,963'Cephalosporins'19965,525,594'Treatment of hyperandrogenic disorders'19965,494,907'11-.beta. substituted-19-nor steroids'19965,434,176'Phenylimidazolidines'19955,411,981'Phenylimidazolidines having antiandrogenic activity'19955,385,897'4-thia-1-aza-bicyclo[4,2,0]oct-2-ene derivatives'19955,378,697'Cephalosporins'19955,182,381'Intermediates for 3-keto-19-nor-.DELTA..sup.4,9 -steroids'19935,064,822'Novel 3-keto-19-nor-.DELTA..sup.4,9 -steroids'19915,043,332'Novel 11.beta.-substituted -19-nor-steriods'19914,978,657'Novel 11.beta.-substituted-19-nor-steroids'19904,912,097'Novel 11 .beta.-alkynylphenyl-10-nor-steroids'19904,908,359'1-dethia-2-thia-cephalosporanic acids'19904,753,932'Novel 10-substituted steroids'19884,634,695'Steroid derivatives'19874,634,696'Novel 11 beta-substituted-19-nor-steroids'19874,547,493'Novel 11.beta.-substituted-19-nor-steroids'19854,540,686'3-Keto-19-nor-.DELTA..sup.4,9 -steroids'19854,519,946'Steroids'19854,515,787'Steroids'19854,477,445'3-Keto-19-nor-.DELTA.4,9-steroids'19844,447,424'Steroid derivatives'19844,386,085'Novel steroids'19834,353,899'Novel 16.alpha.-methyl-pregnane'19824,303,654'Novel 21-chloro-20-acetylenic steroids'19814,272,530'.DELTA..sup.1,3,5(10) -Estratrienes'19814,257,948'Novel epoxidation agent and process'19814,233,296'11.beta.-Substituted-.DELTA..sup.4,9 -estradienes'19804,233,297'Novel .DELTA..sup.4 -androstenes'19804,232,015'Novel .DELTA..sup.4 -androstenes'19804,168,306'17.alpha.-Acetylenic-.DELTA..sup.4 -androstenes'19794,147,695'11.beta.-Substituted-.DELTA..sup.9 -steroids'1979Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1979–1998Patents assigned to ROUSSEL UCLAF (47)· patent assignee history
1979–1981Based in Le Blanc Mesnil, FR· patent location history
1980–2004Based in Pantin, FR· patent location history
1999–2001Patents assigned to HOECHST MARION ROUSSEL INC (7)· patent assignee history
2001–2004Patents assigned to AVENTIS PHARMA SA (13)· patent assignee history
2001Patents assigned to GENENTECH INC (1)· patent assignee history
2002Patents assigned to GENETECH (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ROUSSEL UCLAF | 47 | 1979–1998 |
| AVENTIS PHARMA SA | 13 | 2001–2004 |
| HOECHST MARION ROUSSEL INC | 7 | 1999–2001 |
| GENENTECH INC | 1 | 2001 |
| GENETECH | 1 | 2002 |
Locations
| Location | Patents | Span |
|---|---|---|
| Pantin, FR | 65 | 1980–2004 |
| Le Blanc Mesnil, FR | 4 | 1979–1981 |